Studies have shown that ANRIL regulates VSMC growth through CDKN2A/B (known as p16INK4A/p15INKB), which participates directly in the pathogenesis of atherosclerosis [66]. This evidence concerns the gene CDKN2B-AS1 and atherosclerosis.